February 1, 2011

SUPPLIER NEWS — The Food and Drug Administration has approved a generic drug made by Watson Pharmaceuticals for cancer-related breakthrough pain, Watson said. The drug is a generic version of Cephalon’s Fentora, which had sales of around $179 million during the 12-month period ended in November 2010, according to IMS Health.


January 18, 2011

Generic drug maker Sandoz has started a mid-stage clinical trial of a monoclonal antibody used to treat cancer and autoimmune disease, the company said.

January 12, 2011

Drug maker Merck and drug industry services organization Parexel International will work together to develop biosimilars, the two said Wednesday.

January 6, 2011

A U.S. biotech company plans to develop a biosimilar of a monoclonal antibody used to treat cancers and autoimmune disorders.

December 20, 2010

Drugs for bacterial infections and cancer, and one that could help shape regulations for biosimilars, are featured in the Food and Drug Administration’s annual "Generic Drug Roundup."

December 7, 2010

Drug makers Momenta Pharmaceuticals and Sandoz have filed a lawsuit against Teva Pharmaceutical Industries in the U.S. District Court for the District of Massachusetts, alleging infringement of two patents related to a generic blood-thinning drug.

November 14, 2010

William Gibson, the science-fiction author who helped create the cyberpunk genre in the 1980s and...

November 9, 2010

To express it in modern parlance, follow-on biologics will be a hot mess....

November 2, 2010

The main lobbies for the biotechnology and generic drug industries, and a leading manufacturer of...

November 1, 2010

Amgen's SVP research and development, Joe Miletich, urged members of a Food and Drug Administration...

November 1, 2010

In testimony before the Food and Drug Administration on Tuesday, CVS Caremark’s SVP specialty pharmacy...

November 1, 2010

The Food and Drug Administration should ensure patient access, safety and efficacy; create a transparent...

September 29, 2010

The Food and Drug Administration declined to approve a Teva biosimilar, the generic drug maker...

September 28, 2010

While biosimilars promise to provide therapies for a wide range of diseases, their biggest fans...

September 26, 2010

Biosimilars, biogenerics, follow-on biologics—whatever the designation one prefers for knockoffs of biotech drugs—they will soon...

September 26, 2010

Many generic drug companies have long marketed branded drugs on the side, but lately, some...

September 20, 2010

The Food and Drug Administration is looking for input on regulations concerning knock-off versions of...

August 23, 2010

French drug maker Sanofi-Aventis is suing to stop Sandoz’ generic version of its blood thinner...

August 15, 2010

A lot of generic drug companies have conducted business in the branded drug market on...

August 8, 2010

Generic drug maker Dr. Reddy’s has launched in India the world’s first follow-on version of...

August 2, 2010

Hospira had net sales of $968 million and profits of $83.5 million in second quarter...

July 20, 2010

Biosimilars may have cleared their biggest stretch of wilderness thanks to their inclusion in the...

July 14, 2010

Watson Pharmaceuticals will work with a venture-backed firm to develop a biosimilar treatment for female...

June 6, 2010

After nearly a decade at the helm, Generic Pharmaceutical Association president and CEO Kathleen Jaeger...